AGA Clinical Practice Update on Functional Heartburn: Expert Review.

Best Practice Advice 1 A diagnosis of functional heartburn should be considered when retrosternal burning pain or discomfort persists despite maximal (double-dose) proton pump inhibitor (PPI) therapy taken appropriately before meals during a 3-month period. Best Practice Advice 2 A diagnosis of functional heartburn requires upper endoscopy with esophageal biopsies to rule out anatomic and mucosal abnormalities, esophageal high-resolution manometry to rule out major motor disorders, and pH monitoring off PPI therapy (or pH-impedance monitoring on therapy in patients with proven gastroesophageal reflux disease [GERD]), to document physiologic levels of esophageal acid exposure in the distal esophagus with absence of reflux–symptom association (ie, negative symptom index and symptom association probability). Best Practice Advice 3 Overlap of functional heartburn with proven GERD is diagnosed according to Rome IV criteria when heartburn persists despite maximal PPI therapy in patients with history of proven GERD (ie, positive pH study, erosive esophagitis, Barrett’s esophagus, or esophageal ulcer), and pH impedance testing on PPI therapy demonstrates physiologic acid exposure without reflux–symptom association (ie, negative symptom index and symptom association probability). Best Practice Advice 4 PPIs have no therapeutic value in functional heartburn, the exception being proven GERD that overlaps with functional heartburn. Best Practice Advice 5 Neuromodulators, including tricyclic antidepressants, selective serotonin reuptake inhibitors, tegaserod, and histamine-2 receptor antagonists have benefit as either primary therapy in functional heartburn or as add-on therapy in functional heartburn that overlaps with proven GERD. Best Practice Advice 6 Based on available evidence, acupuncture and hypnotherapy may have benefit as monotherapy in functional heartburn, or as adjunctive therapy combined with other therapeutic modalities. Best Practice Advice 7 Based on available evidence, anti-reflux surgery and endoscopic GERD treatment modalities have no therapeutic benefit in functional heartburn and should not be recommended.

[1]  J. Pandolfino,et al.  Phenotypes of Gastroesophageal Reflux Disease: Where Rome, Lyon, and Montreal Meet. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[2]  E. Savarino,et al.  Mean Nocturnal Baseline Impedance Correlates with Symptom Outcome When Acid Exposure Time is Inconclusive on Esophageal Reflux Monitoring. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[3]  C. Gyawali,et al.  High-resolution Manometry can Characterize Esophagogastric Junction Morphology and Predict Esophageal Reflux Burden , 2020, Journal of clinical gastroenterology.

[4]  Grant D. Huang,et al.  Randomized Trial of Medical versus Surgical Treatment for Refractory Heartburn. , 2019, The New England journal of medicine.

[5]  S. Horgan,et al.  Clinical Presentation of Gastroesophageal Reflux Disease: A Prospective Study on Symptom Diversity and Modification of Questionnaire Application , 2019, Digestive Diseases.

[6]  E. Savarino,et al.  Esophageal mucosal innervation in functional heartburn: Closer to healthy asymptomatic subjects than to non‐erosive reflux disease patients , 2019, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[7]  R. Fass,et al.  Most Patients With Gastroesophageal Reflux Disease Who Failed Proton Pump Inhibitor Therapy Also Have Functional Esophageal Disorders , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8]  J. Tack,et al.  Relations between food intake, psychological distress, and gastrointestinal symptoms: A diary study , 2019, United European gastroenterology journal.

[9]  R. Fass,et al.  Overlap Between GERD and Functional Esophageal Disorders—a Pivotal Mechanism for Treatment Failure , 2019, Current Treatment Options in Gastroenterology.

[10]  A. Hungin,et al.  Revisiting Montreal: New Insights into Symptoms and Their Causes, and Implications for the Future of GERD , 2018, The American Journal of Gastroenterology.

[11]  R. Penagini,et al.  Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non‐erosive reflux disease , 2018, Alimentary pharmacology & therapeutics.

[12]  W. Whitehead,et al.  Oesophageal symptoms are common and associated with other functional gastrointestinal disorders (FGIDs) in an English-speaking Western population , 2018, United European gastroenterology journal.

[13]  C. Gyawali,et al.  Chronic Cough Is Associated With Long Breaks in Esophageal Peristaltic Integrity on High-resolution Manometry , 2018, Journal of neurogastroenterology and motility.

[14]  S. Callegari-Jacques,et al.  Juice Test for Identification of Nonerosive Reflux Disease in Heartburn Patients , 2018, Journal of neurogastroenterology and motility.

[15]  Minhu Chen,et al.  The Rome IV versus Rome III criteria for heartburn diagnosis: A comparative study , 2018, United European gastroenterology journal.

[16]  E. Savarino,et al.  Modern diagnosis of GERD: the Lyon Consensus , 2018, Gut.

[17]  D. Drossman,et al.  Neuromodulators for Functional Gastrointestinal Disorders (Disorders of Gut-Brain Interaction): A Rome Foundation Working Team Report. , 2017, Gastroenterology.

[18]  R. Fass,et al.  Reflux Hypersensitivity: A New Functional Esophageal Disorder , 2017, Journal of neurogastroenterology and motility.

[19]  J. Pandolfino,et al.  A review of medical therapy for proton pump inhibitor nonresponsive gastroesophageal reflux disease. , 2017, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[20]  C. Gyawali,et al.  Management of Gastroesophageal Reflux Disease. , 2017, Gastroenterology.

[21]  C. Schleck,et al.  Multiple functional gastrointestinal disorders linked to gastroesophageal reflux and somatization: A population‐based study , 2017, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[22]  S. Roman,et al.  A study with pharyngeal and esophageal 24‐hour pH–impedance monitoring in patients with laryngopharyngeal symptoms refractory to proton pump inhibitors , 2017, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[23]  E. Savarino,et al.  Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD , 2016, The American Journal of Gastroenterology.

[24]  A. Leasure,et al.  Comparison of Rectal and Esophageal Sensitivity in Women With Functional Heartburn , 2016, Gastroenterology Nursing.

[25]  J. Pandolfino,et al.  Feasibility and acceptability of esophageal-directed hypnotherapy for functional heartburn. , 2016, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[26]  A. Bredenoord,et al.  Esophageal acid sensitivity and mucosal integrity in patients with functional heartburn , 2016, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[27]  J. Dent,et al.  Sleep disturbance due to heartburn and regurgitation is common in patients with functional dyspepsia , 2016, United European gastroenterology journal.

[28]  J. Pandolfino,et al.  Functional Esophageal Disorders. , 2016, Gastroenterology.

[29]  N. Pausawasdi,et al.  Imipramine for Treatment of Esophageal Hypersensitivity and Functional Heartburn: A Randomized Placebo-Controlled Trial , 2016, The American Journal of Gastroenterology.

[30]  A. Bredenoord,et al.  Patients with refractory reflux symptoms often do not have GERD , 2015, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[31]  E. Savarino,et al.  Association between baseline impedance values and response proton pump inhibitors in patients with heartburn. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[32]  R. Penagini,et al.  Inconsistency in the Diagnosis of Functional Heartburn: Usefulness of Prolonged Wireless pH Monitoring in Patients With Proton Pump Inhibitor Refractory Gastroesophageal Reflux Disease , 2015, Journal of neurogastroenterology and motility.

[33]  P J Kahrilas,et al.  The Chicago Classification of esophageal motility disorders, v3.0 , 2015, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[34]  A. Smout,et al.  Systematic review: questionnaires for assessment of gastroesophageal reflux disease. , 2015, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[35]  D. Consonni,et al.  Usefulness of low- and high-volume multiple rapid swallowing during high-resolution manometry. , 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[36]  R. Fass,et al.  The role of pain modulators in esophageal disorders – no pain no gain , 2014, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[37]  Mohammad R. Ostovaneh,et al.  Comparing omeprazole with fluoxetine for treatment of patients with heartburn and normal endoscopy who failed once daily proton pump inhibitors: Double‐blind placebo‐controlled trial , 2014, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[38]  M. Aloysius,et al.  The effect of melatonin in functional heartburn: A randomized, placebo-controlled clinical trial , 2014 .

[39]  E. Savarino,et al.  Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? , 2014, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[40]  S. Roman,et al.  The Chicago classification for achalasia in a French multicentric cohort. , 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[41]  E. Savarino,et al.  How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? , 2012, World journal of gastroenterology.

[42]  G. Boeckxstaens,et al.  Baclofen improves symptoms and reduces postprandial flow events in patients with rumination and supragastric belching. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[43]  M. Vaezi,et al.  Significance and degree of reflux in patients with primary extraesophageal symptoms , 2011, The Laryngoscope.

[44]  S. B. des Varannes,et al.  Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease , 2011, Gut.

[45]  M. Sugiyama,et al.  Long-term outcomes of combination of endoscopic submucosal dissection and laparoscopic lymph node dissection without gastrectomy for early gastric cancer patients who have a potential risk of lymph node metastasis. , 2011, Gastrointestinal endoscopy.

[46]  E. Savarino,et al.  The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease. , 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[47]  M. Fox,et al.  Failure to respond to physiologic challenge characterizes esophageal motility in erosive gastro‐esophageal reflux disease , 2011, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[48]  D. García-Compeán,et al.  Prevalence of eosinophilic esophagitis in patients with refractory gastroesophageal reflux disease symptoms: A prospective study. , 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[49]  V. Garrigues,et al.  High Prevalence of Heartburn and Low Acid Sensitivity in Patients with Idiopathic Achalasia , 2011, Digestive Diseases and Sciences.

[50]  U. Schöning,et al.  Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study , 2010, Gut.

[51]  T. Ang,et al.  To Bravo or not? A comparison of wireless esophageal pH monitoring and conventional pH catheter to evaluate non‐erosive gastroesophageal reflux disease in a multiracial Asian cohort , 2010, Journal of digestive diseases.

[52]  J. Dent,et al.  Development of the GerdQ, a tool for the diagnosis and management of gastro‐oesophageal reflux disease in primary care , 2009, Alimentary pharmacology & therapeutics.

[53]  E. Savarino,et al.  Reflux patterns in patients with short‐segment Barrett’s oesophagus: a study using impedance‐pH monitoring off and on proton pump inhibitor therapy , 2009, Alimentary pharmacology & therapeutics.

[54]  M. Vaezi,et al.  Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[55]  L. Chan,et al.  Obesity and Gastroesophageal Reflux: Quantifying the Association Between Body Mass Index, Esophageal Acid Exposure, and Lower Esophageal Sphincter Status in a Large Series of Patients with Reflux Symptoms , 2009, Journal of Gastrointestinal Surgery.

[56]  Koji Arizono,et al.  Why Public Health Agencies Cannot Depend on Good Laboratory Practices as a Criterion for Selecting Data: The Case of Bisphenol A , 2008, Environmental health perspectives.

[57]  A. Bredenoord,et al.  Esophageal pH-Impedance Monitoring in Patients With Therapy-Resistant Reflux Symptoms: ‘On’ or ‘Off’ Proton Pump Inhibitor? , 2008, The American Journal of Gastroenterology.

[58]  W. Chey,et al.  The influence of co‐morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro‐oesophageal reflux disease , 2008, Alimentary pharmacology & therapeutics.

[59]  B. Naliboff,et al.  The effect of auditory stress on perception of intraesophageal acid in patients with gastroesophageal reflux disease. , 2008, Gastroenterology.

[60]  S. Quan,et al.  Sleep deprivation is hyperalgesic in patients with gastroesophageal reflux disease. , 2007, Gastroenterology.

[61]  R. Fass,et al.  Clinical trial: acupuncture vs. doubling the proton pump inhibitor dose in refractory heartburn , 2007, Alimentary pharmacology & therapeutics.

[62]  J. Richter,et al.  ACG Practice Guidelines: Esophageal Reflux Testing , 2007, The American Journal of Gastroenterology.

[63]  D. O. Castell,et al.  Combined multichannel intraluminal impedance–pH monitoring to select patients with persistent gastro‐oesophageal reflux for laparoscopic Nissen fundoplication , 2006, The British journal of surgery.

[64]  S. Roman,et al.  Ambulatory 24‐h oesophageal impedance–pH recordings: reliability of automatic analysis for gastro‐oesophageal reflux assessment , 2006, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[65]  P. Miner,et al.  Effect of tegaserod on esophageal pain threshold, regurgitation, and symptom relief in patients with functional heartburn and mechanical sensitivity. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[66]  P. Miner,et al.  A single dose of ranitidine 150 mg modulates oesophageal acid sensitivity in patients with functional heartburn , 2004, Alimentary pharmacology & therapeutics.

[67]  L. Swanström,et al.  Outcomes of antireflux surgery in patients with normal preoperative 24-hour pH test results. , 2004, American journal of surgery.

[68]  J. Peters,et al.  Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication , 1998, Journal of Gastrointestinal Surgery.

[69]  G. Domingues,et al.  Impact of prolonged 48-h wireless capsule esophageal pH monitoring on diagnosis of gastroesophageal reflux disease and evaluation of the relationship between symptoms and reflux episodes. , 2011, Arquivos de gastroenterologia.

[70]  R. Fass,et al.  Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment. , 2010, Gastrointestinal endoscopy.